Results 161 to 170 of about 204,688 (384)
Cyclosporine A inhibits Ca2+-dependent stimulation of the Na+/H+ antiport in human T cells. [PDF]
, 1986 P M Rosoff, Geronimo Terres
openalex +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Psoriatic arthritis (PsA) is a chronic inflammatory disease, with prevalence among psoriasis patients ranging from 6% to 42% across populations. Although targeted therapies such as adalimumab (ADA), secukinumab (SEC), and upadacitinib (UPA) have demonstrated efficacy in randomized controlled trials, real‐world head‐to‐head comparisons remain ...
Yiyi Wang +11 more
wiley +1 more source
Incidence of fistulas following human pancreas transplantation [PDF]
, 1987 Abendroth, D. +3 more
core +1 more source
Liver transplantation: an unfinished product. [PDF]
, 1989 Liver transplantation has become an extraordinarily valuable and useful operation, but one that is not perfect and that has not been exploited to anything like its full potential.
Concepcion, W +9 more
core
ENCAPSULATION OF CYCLOSPORINE BY PHOSPHATIDYLINOSITOL-CHOLESTEROL LIPOSOMES
, 1986 NULL AUTHOR_ID
openalex +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent remissions and relapses. Topical anti‐inflammatory steroids are commonly used for treatment, but their long‐term use poses concerns because of potential side effects. Delgocitinib ointment, a Janus kinase inhibitor, has demonstrated efficacy in several clinical
Masatoshi Abe +5 more
wiley +1 more source
Australasian Journal of Dermatology, EarlyView.ABSTRACT Background/Objectives Janus kinase inhibitors (JAKis) have been approved by the Therapeutic Goods Administration for severe alopecia areata (AA) in Australia. However, access is limited as JAKis are not currently subsidised on the Pharmaceutical Benefits Scheme for this indication. This study aimed to establish expert consensus on criteria for
Meryl Thomas +23 more
wiley +1 more source